Skip to main content
CGNX $65.63 +6.56%
CGNX logo

CGNX · Cognex Corp

Track CGNX — free
$65.63 +4.04 (+6.56%) At close · Aug 14
Market Cap
$11.04B
Shares
168.22M
All earnings calls

Earnings call · FY2025 Q2

Cognex Corp Q2 FY2025 Earnings Call

Cognex Corp Q2 FY2025 Earnings Call

Concluded Jul 31, 2025 Audio replay
Jul 31, 2025 1:01:34 72 turns
Period
FY2025 Q2
Runtime
1:01:34
Sources
4 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

AI Technology Leadership and OneVision Platform 33 Packaging Momentum 28 Semi Uncertainty from Tariffs and Trade Policy 27 Profitability and Margin Expansion 22 Consumer Electronics Strength 16 Logistics Growth 16

Management tone

Positive

Net tone +38 · moderate hedging

Grounding quotes
  • “Q2 represents an early but meaningful step forward in this journey marked by continued adjusted EBITDA margin expansion and strong free cash flow generation.”
  • “I'm confident in our direction, proud of our team and excited about what's ahead.”
  • “automotive continued to decline year-over-year as it remains our most challenged vertical, reflecting broad headwinds to this industry.”
  • “we remain cautious about the outlook for auto, as we have previously discussed and continue to anticipate a more modest decline in 2025 relative to last year's 14% contraction.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $249.09M +4.1% YoY
Diluted EPS $0.24 +14.3% YoY
Gross margin 67.4% -2.2 pp YoY
Net income $40.51M +11.9% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Standard Products and Services$216.03M +7.6% YoY
Application Specific Customer Solutions$33.06M -14% YoY

Capital returned

Dividend / share
$0.08
Full-screen source Call document